OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 1 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $4,171,000 | -79.1% | 7,412,756 | -36.1% | 0.00% | -66.7% |
| Q4 2015 | $19,950,000 | -18.5% | 11,598,705 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $24,473,000 | -57.4% | 11,598,705 | 0.0% | 0.00% | -57.1% |
| Q2 2015 | $57,414,000 | -32.7% | 11,598,705 | +6.5% | 0.01% | -36.4% |
| Q1 2015 | $85,302,000 | +32.6% | 10,894,205 | +2.6% | 0.01% | +37.5% |
| Q4 2014 | $64,321,000 | +49.0% | 10,613,981 | +4.8% | 0.01% | +33.3% |
| Q3 2014 | $43,158,000 | -29.6% | 10,130,881 | +2.1% | 0.01% | -25.0% |
| Q2 2014 | $61,315,000 | +36.5% | 9,921,581 | +43.5% | 0.01% | +33.3% |
| Q1 2014 | $44,927,000 | +158.5% | 6,911,881 | +123.9% | 0.01% | +200.0% |
| Q4 2013 | $17,383,000 | -48.1% | 3,087,551 | -43.3% | 0.00% | -60.0% |
| Q3 2013 | $33,463,000 | +58.3% | 5,449,951 | +50.8% | 0.01% | +66.7% |
| Q2 2013 | $21,142,000 | – | 3,614,051 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |